Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-severe Pulmonary Embolism”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT06598930
What this trial is testing

Evaluation of the Effectiveness of Intensive Medical Follow-up with an Advanced Practice Nurse Compared with Medical Follow-up Alone in Non-severe Pulmonary Embolism.

Who this might be right for
Non-severe Pulmonary Embolism
Centre Hospitalier Universitaire Dijon 360
Not applicableLooking for participantsNCT06166329
What this trial is testing

Interest of the Chair Lift Test in the Prognostic Evaluation of Pulmonary Embolism: a Single-center Open Prospective Study

Who this might be right for
Non-severe Pulmonary EmbolismPulmonary EmbolismNon-high-risk Pulmonary Embolism+5 more
University Hospital, Rouen 180
Not applicableStudy completedNCT04452422
What this trial is testing

Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology

Who this might be right for
Deep Venous Thrombosis
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Large-scale testing (Phase 3)Looking for participantsNCT07410117
What this trial is testing

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Who this might be right for
Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals 1,120